Emerging roles of lipids in the modulation of cancer risk and therapy

Presented by

Dr Catherine Field, Dr Robert Chapkin and Dr Keri Marshall

About this talk

Join us for our first webinar on lipids and oncology, presented by Dr. Catherine Field and Dr. Robert Chapkin, two of the world’s leading experts in the molecular mechanisms by which lipids modulate cancer risk and therapy. Together with DSM’s Dr. Keri Marshall, they will discuss the evidence for the use of lipids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), as a part of neoadjuvant therapy for two of the most common cancers: breast and colon. In 2017, there will be an estimated 1,688,780 new cancer cases diagnosed and 600,920 cancer deaths in the US alone. By 2030, the global burden is expected to grow from 14.1 million new cancer cases and 8.2 million cancer deaths worldwide in 2012, to 21.7 million new cancer cases and 13 million cancer deaths, simply due to population growth and longer lifer spans. The future burden may be even larger due to the adoption of certain habits common in Western lifestyles, such as smoking, poor diet, and physical inactivity. Lipids, in particular EPA and DHA, have been shown to play a role in both prevention and treatment of multiple forms of cancer. The webinar will explore the current state of the science for EPA and DHA as a bioactive, including novel research in human cell lines, that show evidence in preclinical models using patient derived xenographs. It will also provide an overview on the potential mechanisms as to how DHA may improve neoadjuvant chemotherapy, while protecting healthy cells.

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (12)
Subscribers (3140)
DSM is a leading global supplier of vitamins, carotenoids, nutritional lipids, nutraceutical ingredients and nutritional premixes to the dietary supplement, food and pharmaceutical industries. With customized support throughout the entire new product development process, we help our customers get to market faster and safer with appealing solutions that work. Nutrition science is at the core of DSM. We are committed to addressing the requirements of people around the world in need of nutritional solutions. Through science, partnerships, communication and advocacy, our Nutrition Science & Advocacy team aims to raise awareness of sound scientific evidence for the role of micronutrients in nutrition, health and wellbeing. The aim of this webinar channel is to provide up-to-date information on the role of micronutrients in supporting human health. Together with guest speakers, our experts deliver relevant discussions on today’s prominent health concerns and highlight key scientific findings on micronutrients and their role in supporting specific health benefits.